0.05Open0.05Pre Close0 Volume123 Open Interest15.00Strike Price0.00Turnover162.95%IV74.39%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier13DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0503Delta0.0391Gamma172.60Leverage Ratio-0.0102Theta0.0001Rho8.69Eff Leverage0.0017Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals (EYPT.US)$
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$
📊⚡️📊
No comment yet